Skip to content

Clinical study of central-peripheral closed-loop magnetic stimulation in the treatment of neurogenic bladder after spinal cord injury

Clinical study of central-peripheral closed-loop magnetic stimulation in the treatment of neurogenic bladder after spinal cord injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126232
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal cord injury

Interventions

Test team:Experimental group : on the basis of the treatment of the control group, repetitive transcranial magnetic stimulation ( rTMS ) combined with peripheral magnetic stimulation of sacral nerve r
Control group:Control group : conventional bladder rehabilitation treatment Intermittent clean catheterization ( CIC ) combined with basic bladder training was performed with reference to neurogenic

Sponsors

Gansu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.According to the International Standard for Neurological Classification of Spinal Cord Injury ( 2019 Edition ), the diagnosis was confirmed by CT / MRI, and the shock stage of spinal cord was over. 2.urodynamic diagnosis of detrusor areflexia / low tension neurogenic bladder, residual urine volume > 100 mL ; 3.18-65 years old, ASIA grade B-D ; 4.stable vital signs, clear consciousness, can cooperate with treatment and evaluation ; 5.signed the informed consent form, this study was approved by the hospital ethics committee.

Exclusion criteria

Exclusion criteria: 1.craniocerebral injury, epilepsy, intracranial metal implants, cardiac pacemaker ; 2. severe urinary tract infection, calculi, urethral obstruction, renal insufficiency ; 3. pregnancy, cognitive impairment, mental illness ; 4.Patients received magnetic stimulation or other neuromodulation therapy in the past 1 month.

Design outcomes

Primary

MeasureTime frame
Bladder residual urine volume;Maximum bladder capacity;Average daily urination times;

Secondary

MeasureTime frame
24-hour urine leakage times;International Lower Urinary Tract Symptom Score;Quality of life score;Incidence of adverse reactions;

Countries

China

Contacts

Public ContactLi Chao

Gansu Provincial Hospital of Traditional Chinese Medicine

1335779645@qq.com+86 189 1909 0630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026